← All stocks

Q32 Bio Inc.

FIXX Net selling
CIK 0001661998 #3147 in the set updated 17 Sep 2026
Bought (120 mo)
$82.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$110.15M
$7.45K on a plan · $1.45M straight out of an exercise
Sold at will
$108.69M
96 of 119 sales
Net
−$28.15M
−$26.69M against sales at will

By person

28 insiders · 134 transactions
8.8×

Jodie Morrison holds 8.8 times base salary in stock. $5.68M of shares against $645.60K in salary for 2025.

Salary from the company's own proxy. The shares are what Jodie Morrison last reported holding, valued at $16.56, the price Common Stock was last bought or sold at on the open market here, on 25 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
5AM Ventures IV, L.P. entity
10% owner
$37.36M (14)
−$37.36M
6,903,511
$114.32M
+86.7%
PARMAR KUSH
Director
$37.36M (14)
−$37.36M
181,435
$3.00M
ORBIMED ADVISORS LLC entity
Director
$15.00M (2)
+$15.00M
625,000
$10.35M
Xu Diyong
Director
$15.00M (2)
+$15.00M
625,000
$10.35M
Temasek Holdings (Private) Ltd entity
10% owner
$10.00M (1)
+$10.00M
3,220,293
$53.33M
Vida Ventures, LLC entity
10% owner
$6.00M (1)
+$6.00M
770,845
$12.77M
Rock Springs Capital Management LP entity
10% owner
$4.00M (1)
+$4.00M
645,845
$10.70M
Flynn James E
10% owner
$32.00M (3)
$29.32M (13)
+$2.68M
4,087,305
$67.69M
TZIANABOS ARTHUR
Director
$2.07M (14)
−$2.07M
7,983
$132.20K
−88.3%
Seymour Albert
See Remarks
$1.66M (16)
−$1.66M
150,874
$2.50M
−36.3%
Smith W Bradford
See remarks
$1.27M (13) scheduled
−$1.27M
14,219
$235.47K
Rasty Siyamak
Chief Operating Officer
$321.78K (2)
−$321.78K
222,707
$3.69M
−6.7%
Morrison Jodie Pope
CEO
$304.48K (4)
−$304.48K
343,259
$5.68M
Kelly Timothy P
Chief Operating Officer
$249.86K (10) scheduled
−$249.86K
2,224
$36.83K
Kalowski Lee
CFO and President
$122.84K (4)
−$122.84K
138,471
$2.29M
Violette Shelia M.
Chief Scientific Officer
$64.43K (3)
−$64.43K
127,771
$2.12M
Alloway Paul
See Remarks
$30.77K (4)
−$30.77K
51,566
$853.93K
+140.3%
Cohn Gabriel
Chief Medical Officer
$6.28K (1)
−$6.28K
2,629
$43.54K
Blum Michael Lee
Chief Commercial Officer
$3.41K (1)
−$3.41K
13,538
$224.19K
+61.1%
Michaud Charles Jr
See Remarks
$2.79K (2)
−$2.79K
18,046
$298.84K
+97.4%
Jordan Julie
Chief Medical Officer
$2.71K (4) scheduled
−$2.71K
7,496
$124.13K
+197.6%
ARCH Venture Fund VIII, L.P. entity
10% owner
11,837,389
$196.03M
+95.1%
GILLIS STEVEN
Director
6,068,695
$100.50M
Novartis Institutes for BioMedical Research, Inc. entity
10% owner
1,979,226
$32.78M
SHAH MAHENDRA
Director
1,159,742
$19.21M
Manke Isaac
Director
53,521
$886.31K
Campagna Jason
Chief Medical Officer
37,500
$621.00K
Gregory Richard J.
Director
10,806
$178.95K

No percentages here. This company's share count has moved by a factor of 2.4 over the window, from 12,180,701 to 29,769,466 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Violette Shelia M.
25 Aug 2026
Chief Scientific Officer
Sell
2,798
$16.56
$46.33K
Kalowski Lee
25 Aug 2026
CFO and President
Sell
3,972
$16.56
$65.78K
Morrison Jodie Pope
25 Aug 2026
CEO
Sell
9,845
$16.56
$163.03K
Manke Isaac
30 Jun 2026
Director
Exercised, kept
53,521
$2.80
$149.86K
ORBIMED ADVISORS LLC
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
ORBIMED ADVISORS LLC
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
Xu Diyong
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Xu Diyong
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
Violette Shelia M.
25 Feb 2026
Chief Scientific Officer
Sell
2,815
$4.51
$12.71K
Morrison Jodie Pope
25 Feb 2026
CEO
Sell
9,896
$4.51
$44.67K
Kalowski Lee
25 Feb 2026
CFO and President
Sell
3,995
$4.51
$18.04K
Kalowski Lee
2 Dec 2025
CFO and President
Sell
9,072
$3.46
$31.40K
Morrison Jodie Pope
2 Dec 2025
CEO
Sell
22,506
$3.46
$77.87K
Kalowski Lee
26 Aug 2025
CFO and President
Sell
4,240
$1.80
$7.64K
Violette Shelia M.
26 Aug 2025
Chief Scientific Officer
Sell
2,990
$1.80
$5.38K
Morrison Jodie Pope
26 Aug 2025
CEO
Sell
10,494
$1.80
$18.90K
Violette Shelia M.
15 Oct 2024
Chief Scientific Officer
Exercised, kept
6,000
$7.29
$43.74K
Violette Shelia M.
11 Oct 2024
Chief Scientific Officer
Exercised, kept
4,574
$3.12
$14.27K
Violette Shelia M.
8 Oct 2024
Chief Scientific Officer
Exercised, kept
13,300
$3.12
$41.50K
Michaud Charles Jr
25 Mar 2024
See Remarks
Sell
75
$24.20
$1.82K
Alloway Paul
25 Mar 2024
See Remarks
Sell
268
$24.21
$6.49K
TZIANABOS ARTHUR
25 Mar 2024
Director
Sold after exercise
265
$24.20
$6.41K
TZIANABOS ARTHUR
9 Jan 2024
Director
Sold on a plan
13,037
$0.57
$7.45K
Michaud Charles Jr
3 Jan 2024
See Remarks
Sell
1,708
$0.57
$975.27
Alloway Paul
3 Jan 2024
See Remarks
Sell
7,280
$0.57
$4.12K
Seymour Albert
6 Sep 2023
See Remarks
Sold after exercise
1,448
$1.15
$1.67K
Jordan Julie
3 Aug 2023
Chief Medical Officer
Sold after exercise
1,308
$1.39
$1.82K
Jordan Julie
3 Aug 2023
Chief Medical Officer
Sold after exercise
109
$1.39
$151.51
Jordan Julie
3 Aug 2023
Chief Medical Officer
Sold after exercise
436
$1.39
$606.04
Jordan Julie
2 Aug 2023
Chief Medical Officer
Sold after exercise
99
$1.31
$129.69
Alloway Paul
2 Mar 2023
See Remarks
Sell
10,965
$1.45
$15.86K
TZIANABOS ARTHUR
9 Jan 2023
Director
Sell
10,616
$1.39
$14.76K
Seymour Albert
9 Jan 2023
See Remarks
Sell
3,620
$1.39
$5.03K
Smith W Bradford
9 Jan 2023
See Remarks
Sell
3,729
$1.39
$5.19K
Alloway Paul
9 Jan 2023
See Remarks
Sell
3,090
$1.39
$4.30K
Blum Michael Lee
9 Jan 2023
Chief Commercial Officer
Sell
2,454
$1.39
$3.41K
TZIANABOS ARTHUR
5 Jan 2022
President & CEO
Sell
5,354
$3.78
$20.24K
Cohn Gabriel
5 Jan 2022
Chief Medical Officer
Sell
1,661
$3.78
$6.28K
Seymour Albert
5 Jan 2022
Chief Scientific Officer
Sell
1,661
$3.78
$6.28K
Kelly Timothy P
5 Jan 2022
Chief Operating Officer
Sell
1,406
$3.78
$5.31K
Smith W Bradford
5 Jan 2022
CFO & Treasurer
Sell
2,182
$3.78
$8.25K
Kelly Timothy P
3 Sep 2021
See Remarks.
Sell
54
$7.70
$415.80
Kelly Timothy P
1 Mar 2021
See Remarks.
Sold after exercise
6,232
$11.16
$69.56K
Smith W Bradford
8 Feb 2021
CFO & Treasurer
Sold after exercise
13,500
$14.25
$192.42K
Kelly Timothy P
2 Feb 2021
See Remarks
Sold after exercise
500
$13.00
$6.50K
Kelly Timothy P
1 Feb 2021
See Remarks
Sold after exercise
4,000
$12.37
$49.46K
Kelly Timothy P
12 Jan 2021
See Remarks
Sold after exercise
500
$13.00
$6.50K
Seymour Albert
7 Jan 2021
Chief Scientific Officer
Sell
5,103
$12.05
$61.47K
Seymour Albert
6 Jan 2021
Chief Scientific Officer
Sell
9,897
$12.06
$119.40K
Seymour Albert
5 Jan 2021
Chief Scientific Officer
Sell
10,000
$11.44
$114.42K
Kelly Timothy P
4 Jan 2021
See Remarks
Sold after exercise
4,000
$11.50
$45.98K
5AM Ventures IV, L.P.
22 Dec 2020
10% owner
Sell indirect
20,000
$12.82
$256.40K
5AM Ventures IV, L.P.
22 Dec 2020
10% owner
Sell indirect
480,000
$12.82
$6.15M
PARMAR KUSH
22 Dec 2020
Director
Sell indirect
20,000
$12.82
$256.40K
PARMAR KUSH
22 Dec 2020
Director
Sell indirect
480,000
$12.82
$6.15M
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
13,703
$11.88
$162.79K
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
6,297
$13.06
$82.24K
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
328,862
$11.88
$3.91M
5AM Ventures IV, L.P.
14 Dec 2020
10% owner
Sell indirect
151,138
$13.06
$1.97M
PARMAR KUSH
14 Dec 2020
Director
Sell indirect
13,703
$11.88
$162.79K
PARMAR KUSH
14 Dec 2020
Director
Sell indirect
6,297
$13.06
$82.24K
PARMAR KUSH
14 Dec 2020
Director
Sell indirect
328,862
$11.88
$3.91M
PARMAR KUSH
14 Dec 2020
Director
Sell indirect
151,138
$13.06
$1.97M
Kelly Timothy P
17 Mar 2020
See Remarks
Sell
1,315
$13.01
$17.11K
TZIANABOS ARTHUR
3 Feb 2020
President & CEO
Sell
12,500
$16.16
$202.02K
Smith W Bradford
3 Feb 2020
CFO, Treasurer & Secretary
Sold after exercise
12,000
$16.16
$193.87K
Flynn James E
30 Jan 2020
10% owner
Sell indirect
509,970
$15.45
$7.88M
Flynn James E
29 Jan 2020
10% owner
Sell indirect
8,857
$15.45
$136.81K
Flynn James E
28 Jan 2020
10% owner
Sell indirect
65,891
$15.51
$1.02M
Flynn James E
27 Jan 2020
10% owner
Sell indirect
193,359
$15.77
$3.05M
Flynn James E
24 Jan 2020
10% owner
Sell indirect
380,256
$15.69
$5.96M
Smith W Bradford
2 Jan 2020
CFO, Treasurer & Secretary
Sold after exercise
6,000
$20.50
$122.98K
Seymour Albert
2 Jan 2020
Chief Scientific Officer
Sell
9,133
$20.50
$187.22K
TZIANABOS ARTHUR
2 Jan 2020
President & CEO
Sell
12,500
$20.50
$256.19K
Flynn James E
24 Dec 2019
10% owner
Sell indirect
151,233
$21.95
$3.32M
Flynn James E
24 Dec 2019
10% owner
Sell indirect
198,767
$21.95
$4.36M
Flynn James E
23 Dec 2019
10% owner
Sell indirect
56,595
$21.83
$1.24M
Flynn James E
23 Dec 2019
10% owner
Sell indirect
74,384
$21.83
$1.62M
Flynn James E
20 Dec 2019
10% owner
Sell indirect
9,130
$21.50
$196.30K
Flynn James E
20 Dec 2019
10% owner
Sell indirect
11,999
$21.50
$257.98K
Flynn James E
19 Dec 2019
10% owner
Sell indirect
5,454
$21.68
$118.22K
Flynn James E
19 Dec 2019
10% owner
Sell indirect
7,168
$21.68
$155.37K
Seymour Albert
2 Dec 2019
Chief Scientific Officer
Sell
9,300
$16.23
$150.97K
TZIANABOS ARTHUR
2 Dec 2019
President & CEO
Sell
12,500
$16.25
$203.18K
Smith W Bradford
2 Dec 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$16.21
$97.27K
Seymour Albert
29 Nov 2019
Chief Scientific Officer
Sell
9,300
$16.06
$149.39K
TZIANABOS ARTHUR
29 Nov 2019
President & CEO
Sell
12,500
$16.04
$200.56K
Smith W Bradford
29 Nov 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$16.00
$96.00K
Gregory Richard J.
18 Nov 2019
Director
Exercised, kept
10,806
$0.03
$324.18
Seymour Albert
1 Oct 2019
Chief Scientific Officer
Sell
100
$18.23
$1.82K
Seymour Albert
1 Oct 2019
Chief Scientific Officer
Sell
9,200
$17.38
$159.94K
TZIANABOS ARTHUR
1 Oct 2019
President & CEO
Sell
100
$18.23
$1.82K
TZIANABOS ARTHUR
1 Oct 2019
President & CEO
Sell
12,400
$17.39
$215.64K
Smith W Bradford
1 Oct 2019
CFO, Treasurer & Secretary
Sold after exercise
100
$18.23
$1.82K
Smith W Bradford
1 Oct 2019
CFO, Treasurer & Secretary
Sold after exercise
5,900
$17.38
$102.54K
Kelly Timothy P
5 Sep 2019
See Remarks
Sell
1,166
$19.94
$23.25K
TZIANABOS ARTHUR
3 Sep 2019
President & CEO
Sell
12,500
$18.75
$234.32K
Seymour Albert
3 Sep 2019
Chief Scientific Officer
Sell
9,300
$18.74
$174.28K
Smith W Bradford
3 Sep 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$18.74
$112.42K
TZIANABOS ARTHUR
1 Aug 2019
President & CEO
Sell
12,500
$17.37
$217.11K
Smith W Bradford
1 Aug 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$17.37
$104.19K
Seymour Albert
1 Aug 2019
Chief Scientific Officer
Sell
9,300
$17.37
$161.52K
Rasty Siyamak
9 Jul 2019
Chief Operating Officer
Sell
8,000
$20.00
$160.00K
TZIANABOS ARTHUR
1 Jul 2019
President & CEO
Sell
12,500
$18.98
$237.30K
Smith W Bradford
1 Jul 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$19.00
$113.97K
Seymour Albert
1 Jul 2019
Chief Scientific Officer
Sell
100
$19.56
$1.96K
Seymour Albert
1 Jul 2019
Chief Scientific Officer
Sell
9,200
$18.98
$174.58K
Rasty Siyamak
3 Jun 2019
Chief Operating Officer
Sell
8,000
$20.22
$161.78K
TZIANABOS ARTHUR
3 Jun 2019
President & CEO
Sell
12,500
$19.86
$248.26K
Seymour Albert
3 Jun 2019
Chief Scientific Officer
Sell
9,300
$19.90
$185.09K
Kelly Timothy P
3 Jun 2019
See Remarks
Sell
1,288
$20.00
$25.76K
Smith W Bradford
3 Jun 2019
CFO, Treasurer & Secretary
Sold after exercise
6,000
$19.94
$119.66K
PARMAR KUSH
16 May 2019
Director
Sell indirect
24,600
$21.47
$528.16K
PARMAR KUSH
16 May 2019
Director
Sell indirect
590,400
$21.47
$12.68M
5AM Ventures IV, L.P.
16 May 2019
10% owner
Sell indirect
24,600
$21.47
$528.16K
5AM Ventures IV, L.P.
16 May 2019
10% owner
Sell indirect
590,400
$21.47
$12.68M
Flynn James E
12 Apr 2019
Director
Buy indirect
533,333
$22.50
$12.00M
PARMAR KUSH
10 Dec 2018
Director
Sell indirect
623
$26.01
$16.20K
PARMAR KUSH
10 Dec 2018
Director
Sell indirect
14,952
$26.01
$388.83K
5AM Ventures IV, L.P.
10 Dec 2018
10% owner
Sell indirect
623
$26.01
$16.20K
5AM Ventures IV, L.P.
10 Dec 2018
10% owner
Sell indirect
14,952
$26.01
$388.83K
5AM Ventures IV, L.P.
23 Nov 2018
10% owner
Sell indirect
1,187
$20.04
$23.78K
5AM Ventures IV, L.P.
23 Nov 2018
10% owner
Sell indirect
28,495
$20.04
$570.93K
PARMAR KUSH
23 Nov 2018
Director
Sell indirect
1,187
$20.04
$23.78K
PARMAR KUSH
23 Nov 2018
Director
Sell indirect
28,495
$20.04
$570.93K
5AM Ventures IV, L.P.
16 Nov 2018
10% owner
Sell indirect
21,036
$20.20
$424.93K
5AM Ventures IV, L.P.
16 Nov 2018
10% owner
Sell indirect
504,864
$20.20
$10.20M
PARMAR KUSH
16 Nov 2018
Director
Sell indirect
21,036
$20.20
$424.93K
PARMAR KUSH
16 Nov 2018
Director
Sell indirect
504,864
$20.20
$10.20M
Temasek Holdings (Private) Ltd
2 Apr 2018
10% owner
Buy indirect
625,000
$16.00
$10.00M
Vida Ventures, LLC
2 Apr 2018
10% owner
Buy indirect
375,000
$16.00
$6.00M
Rock Springs Capital Management LP
2 Apr 2018
10% owner
Buy indirect
250,000
$16.00
$4.00M
Flynn James E
2 Apr 2018
Director
Buy indirect
625,000
$16.00
$10.00M
Flynn James E
2 Apr 2018
Director
Buy indirect
625,000
$16.00
$10.00M

What was left out

Form 4 filings counted 235
Amendments (4/A) skipped 15
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 22
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 34,811,374
Sales filed before the plan box existed 81
History held since 29 Mar 2018